ghk-cu tolerance desensitization loss of effectiveness long-term use with Semaglutide: Stacking Guide ghk-cu tolerance or desensitization or
Description
The primary defect is missense mutation in the HFE gene resulting in a cysteine to tyrosine substitution at aminoacidic 282 (C282Y), a protein that interacts with transferrin receptor 1 (TfR1) and regulates the expression of hepcidin, a key regulator of iron metabolism represented in Diagram B of Figure 2
References Barnhart, K
doi: 10.1038/s41580-022-00462-1
Starting at lower dose ranges and titrating based on tolerability and response represents a conservative approach consistent with general peptide therapy principles
